We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.45%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.65B
AUM Growth
-$418M
(-14%)
Cap. Flow
-$836M
Cap. Flow
% of AUM
-31.52%
Top 10 Holdings %
Top 10 Hldgs %
11.43%
Holding
1,386
New
205
Increased
583
Reduced
380
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$19.2M |
| 2 |
Merck
MRK
|
+$18.5M |
| 3 |
Philip Morris
PM
|
+$17.3M |
| 4 |
Applied Materials
AMAT
|
+$16.3M |
| 5 |
Broadcom
AVGO
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$41.1M |
| 2 |
Kinder Morgan
KMI
|
+$40.3M |
| 3 |
Enbridge
ENB
|
+$40.2M |
| 4 |
TC Energy
TRP
|
+$35.6M |
| 5 |
Cheniere Energy
LNG
|
+$34.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Healthcare | 16.55% |
| 3 | Industrials | 11.82% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Alector
ALEC
$189M
| $106K | ﹤0.01% |
11,440
+1,188
| +12% | +$10.4K |
|
|
XRN
1102
Chiron Real Estate Inc
XRN
$475M
| $105K | ﹤0.01% |
2,219
+27
| +1% | +$1.22K |
|
1103
NeoGenomics
NEO
$2.14B
| $105K | ﹤0.01% |
11,365
-1,094
| -9% | -$10.2K |
|
1104
Recursion Pharmaceuticals
RXRX
$1.76B
| $105K | ﹤0.01% |
13,581
+1,934
| +17% | +$19K |
|
|
VRAY
1105
DELISTED
ViewRay, Inc.
VRAY
| $101K | ﹤0.01% |
+22,599
| New | +$98.3K |
|
|
SGMO
1106
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $101K | ﹤0.01% |
32,243
+7,562
| +31% | +$29.3K |
|
1107
FIGS
FIGS
$2.39B
| $100K | ﹤0.01% |
+14,921
| New | +$107K |
|
|
BDN
1108
Brandywine Realty Trust
BDN
$530M
| $97.8K | ﹤0.01% |
15,906
+1,233
| +8% | +$7.93K |
|
|
MFGP
1109
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $97.3K | ﹤0.01% |
15,427
+3,994
| +35% | +$24.3K |
|
1110
Caribou Biosciences
CRBU
$165M
| $97.2K | ﹤0.01% |
15,481
-2,831
| -15% | -$25.2K |
|
|
BLUE
1111
DELISTED
bluebird bio
BLUE
| $93.8K | ﹤0.01% |
+678
| New | +$95.5K |
|
|
AXIA
1112
DELISTED
AXIA Energia
AXIA
| $93.2K | ﹤0.01% |
+14,847
| New | +$101K |
|
|
LICY
1113
DELISTED
Li-Cycle Holdings Corp.
LICY
| $90.8K | ﹤0.01% |
2,384
+114
| +5% | +$5.12K |
|
1114
Rackspace Technology
RXT
$1.2B
| $88.9K | ﹤0.01% |
30,138
-4,907
| -14% | -$20.7K |
|
|
OTLY
1115
Oatly Group
OTLY
$419M
| $87.1K | ﹤0.01% |
2,502
+445
| +22% | +$17K |
|
1116
Mizuho Financial
MFG
$127B
| $86.6K | ﹤0.01% |
30,507
+1,045
| +4% | +$2.46K |
|
1117
Ginkgo Bioworks
DNA
$515M
| $84.9K | ﹤0.01% |
1,257
+543
| +76% | +$49.9K |
|
|
HLGN
1118
DELISTED
Heliogen, Inc.
HLGN
| $83.9K | ﹤0.01% |
+3,424
| New | +$154K |
|
1119
Inseego
INSG
$87.7M
| $82.2K | ﹤0.01% |
9,791
-15,041
| -61% | -$226K |
|
|
MESO
1120
Mesoblast
MESO
$2.16B
| $81.7K | ﹤0.01% |
14,040
+1,595
| +13% | +$9.97K |
|
1121
TAL Education Group
TAL
$6.93B
| $81.1K | ﹤0.01% |
+11,503
| New | +$63.8K |
|
1122
SHF Holdings
SHFS
$1.18M
| $78.7K | ﹤0.01% |
2,223
+770
| +53% | +$53.1K |
|
1123
Kinross Gold
KGC
$32.5B
| $77.1K | ﹤0.01% |
18,901
+3,134
| +20% | +$12.4K |
|
1124
BlackSky Technology
BKSY
$1.17B
| $75.1K | ﹤0.01% |
6,097
+1,580
| +35% | +$21K |
|
|
CRDL
1125
Cardiol Therapeutics
CRDL
$169M
| $74.8K | ﹤0.01% |
146,807
+1,375
| +0.9% | +$838 |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q4 2022 Portfolio in Review
As of Q4 2022, Vident Investment Advisory held 1,386 positions worth $2.65B, down 14% from $3.07B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Vident Investment Advisory withdrew a net $836M in Q4 2022, closing 210 positions and reducing 380 holdings. Its most notable exit was TC Energy, an estimated $35.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Vident Investment Advisory opened a new position in WisdomTree Bloomberg US Dollar Bullish Fund worth $7.39M.
- Vident Investment Advisory's largest Q4 2022 buy was WisdomTree Bloomberg US Dollar Bullish Fund: 283,584 shares worth $7.39M.
- Vident Investment Advisory added most to Adobe in Q4 2022, an estimated $19.2M increase.
- Vident Investment Advisory's biggest Q4 2022 reduction was Williams Companies, cutting an estimated $41.1M.
- Vident Investment Advisory fully exited TC Energy in Q4 2022, selling an estimated $35.6M.
- Vident Investment Advisory's ten largest holdings make up 11% of its $2.65B portfolio in Q4 2022.
- Vident Investment Advisory opened 205 new positions and closed 210 in Q4 2022.
- Vident Investment Advisory's portfolio value fell 14% quarter-over-quarter to $2.65B.
Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.